PCV47 DOES THE COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN COMBINATION WITH STATIN THERAPY COMPARED TO STATIN ALONE DIFFER BETWEEN PRIMARY AND SECONDARY PREVENTION?
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.772
https://www.valueinhealthjournal.com/article/S1098-3015(19)33150-X/fulltext
Section Title :
Section Order :
10675
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33150-X&doi=10.1016/j.jval.2019.09.772